Medifarm SRL
Medifarm reported total assets of 878,546 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Apr 2026).
The score of Medifarm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -22 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 18 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medifarm's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 28 Apr 2026
- Year ended 30 Sep 2024filed on 30 Jun 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 21 Mar 2022
Medifarm's financial analysis
- Solvency64.1%sector median: 38.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medifarm
Medifarm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.880.514
- VAT number
- BE0432880514
- Peppol
- Registered · 0208:0432880514 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Dec 1987
- Registered office
- 8310 Bruges
- Latest accounts
- 2025 · filed on 28 Apr 2026
- Activity
- Activities of managing agents of real estate (NACE 68321)
Medifarm (SRL) has been based in Bruges since 1987, active in: activities of managing agents of real estate. For 2025, it reports a net profit of 99 € and equity of 563,490 €; its revenue is not published. Its solvency stands at 64.1%, above the median of its sector (38.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medifarm
Companies in the same business, of comparable size and area, outside its group.
- Bloemendaele Other real estate activities on a fee or contract basis Beernem · balance sheet €2.65m
- Panorama B2B Activities of holding companies Bruges · balance sheet €2.01m
- Dr. D. Maes Other real estate activities on a fee or contract basis Oosterzele · balance sheet 795,067 €
- Gillion Partners Other real estate activities on a fee or contract basis Ixelles · balance sheet 814,112 €
- Backes Joseph Other real estate activities on a fee or contract basis Sankt Vith · balance sheet 784,770 €
- Mandala Realty Other real estate activities on a fee or contract basis Leuven · balance sheet 990,337 €
- JSM Other real estate activities on a fee or contract basis Kortrijk · balance sheet €1.00m
- Meganck Gestion Syndic Other real estate activities on a fee or contract basis Watermael-Boitsfort · balance sheet 745,473 €
Frequently asked questions about Medifarm
What is the revenue of Medifarm?
Medifarm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medifarm?
In Belgium, the VAT number is the company number prefixed with BE: BE0432880514 for Medifarm, if the company is VAT-registered. Its company number (CBE) is 0432.880.514.
Where is the registered office of Medifarm?
According to the CBE register, the registered office of Medifarm is in 8310 Bruges.
What is the equity of Medifarm?
At the close of the 2025 financial year, the equity of Medifarm amounts to 563,490 €, a solvency of 64.1% of total assets.
Who manages Medifarm?
The register lists 1 active mandates at Medifarm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medifarm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →